Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47.
- DOI
- 10.1038/s44321-024-00148-5
- Published
- 2024 Nov
- Container
- EMBO molecular medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s44321-024-00148-5,
title = {Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47.},
author = {Wiseman JP and Scarrott JM and Alves-Cruzeiro J and Saffari A and Böger C and Karyka E and Dawes E and Davies AK and Marchi PM and Graves E and Fernandes F and Yang ZL and Coldicott I and Hirst J and Webster CP and Highley JR and Hackett N and Angyal A and Silva T and Higginbottom A and Shaw PJ and Ferraiuolo L and Ebrahimi-Fakhari D and Azzouz M},
year = {2024},
journal = {EMBO molecular medicine},
doi = {10.1038/s44321-024-00148-5},
url = {https://doi.org/10.1038/s44321-024-00148-5}
}RIS
TY - JOUR TI - Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47. AU - Wiseman JP AU - Scarrott JM AU - Alves-Cruzeiro J AU - Saffari A AU - Böger C AU - Karyka E AU - Dawes E AU - Davies AK AU - Marchi PM AU - Graves E AU - Fernandes F AU - Yang ZL AU - Coldicott I AU - Hirst J AU - Webster CP AU - Highley JR AU - Hackett N AU - Angyal A AU - Silva T AU - Higginbottom A AU - Shaw PJ AU - Ferraiuolo L AU - Ebrahimi-Fakhari D AU - Azzouz M PY - 2024 JO - EMBO molecular medicine DO - 10.1038/s44321-024-00148-5 UR - https://doi.org/10.1038/s44321-024-00148-5 ER -
APA
JP, W., JM, S., J, A., A, S., C, B., E, K., E, D., AK, D., PM, M., E, G., F, F., ZL, Y., I, C., J, H., CP, W., JR, H., N, H., A, A., T, S., A, H., PJ, S., L, F., D, E., & M, A. (2024). Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47.. EMBO molecular medicine. https://doi.org/10.1038/s44321-024-00148-5
Source records
- pubmed · retrieved 2026-09-26T10:35:14.764Z